Merck & Co.’s Ebola vaccine and an antiviral drug from Gilead Sciences Inc. are set for wider use in eastern Democratic Republic of Congo to blunt the fastest-growing Ebola outbreak on record.
Merck & Co.’s Ebola vaccine and an antiviral drug from Gilead Sciences Inc. are set for wider use in eastern Democratic Republic of Congo to blunt the fastest-growing Ebola outbreak on record.
<iframe src="https://statesidedaily.com/embed/cluster/00bf41fc3f2f2fd198e126e91e00c85a1258883c" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Congo Ebola Outbreak: Merck Ervebo Vaccine, Gilead Remdesivir Eyed for Wider Use"></iframe>